Evaluation of a mucoadhesive fenretinide patch for local intraoral delivery: A strategy to reintroduce fenretinide for oral cancer chemoprevention

Carcinogenesis

Volumn 33, Issue 5, 2012, Pages 1098-1105

  Holpuch, Andrew S ^a   Phelps, Maynard P ^a   Desai, Kashappa Goud H ^b   Chen, Wei ^a,c   Koutras, George M ^a   Han, Byungdo B ^a   Warner, Blake M ^a   Pei, Ping ^a   Seghi, Garrett A ^a   Tong, Meng ^a   Border, Michael B ^a   Fields, Henry W ^a   Stoner, Gary D ^d   Larsen, Peter E ^a   Liu, Zhongfa ^a,e   Schwendeman, Steven P ^b   Mallery, Susan R ^a,e  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c ZHEJIANG CANCER HOSPITAL   (China)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4; FENRETINIDE; GLUCURONOSYLTRANSFERASE 1A1; KI 67 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSGLUTAMINASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEEK MUCOSA; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG TISSUE LEVEL; EXPERIMENTAL RABBIT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MOUTH CANCER; MUCOADHESIVE PATCH; NONHUMAN; PRIORITY JOURNAL;

EID: 84860438768     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs122     Document Type: Article

References (25)

1. Holpuch, A.S. et al. (2011) Optimizing therapeutic efficacy of chemopreventive agents: a critical review of delivery strategies in oral cancer chemoprevention clinical trials. J. Carcinog., 10, 23.
2. Mallery, S.R. et al. (2008) Topical application of bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions. Cancer Res., 68, 4945-4957.
3. Shumway, B.S. et al. (2008) Effects of topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions. Clin. Cancer Res., 14, 2421-2430.
4. Ugalde, C.M. et al. (2009) Distribution of anthocyanins delivered from a bioadhesive black raspberry gel following topical intraoral application in normal healthy volunteers. Pharm. Res., 26, 977-986.
5. Clifford, J.L. et al. (1999) Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells. Cancer Res., 59, 14-18.
6. Formelli, F. et al. (1996) Bioactivities of N-(4-hydroxyphenyl)retinamide and retinoyl beta-glucuronide. FASEB J., 10, 1014-1024.
7. Chiesa, F. et al. (2005) Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long-term results. Int. J. Cancer, 115, 625-629.
8. Lippman, S.M. et al. (2006) Fenretinide activity in retinoid-resistant oral leukoplakia. Clin. Cancer Res., 12, 3109-3114.
9. William, W.N. Jr et al. (2009) High-dose fenretinide in oral leukoplakia. Cancer Prev. Res. (Phila), 2, 22-26.
10. Tradati, N. et al. (1994) Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR). Cancer Lett., 76, 109-111
11. Mallery, S.R. et al. (2011) Effects of human oral mucosal tissue, saliva and oral microflora on intraoral metabolism and bioactivation of black raspberry anthocyanins. Cancer Prev. Res. (Phila), 4, 1209-1221.
12. Desai, K.G. et al. (2011) Development and in vitro-in vivo evaluation of fenretinide-loaded oral mucoadhesive patches for site-specific chemoprevention of oral cancer. Pharm. Res., 28, 2599-2609.
13. Vaishampayan, U. et al. (2005) Phase II trial of fenretinide in advanced renal carcinoma. Invest. New Drugs, 23, 179-185.
14. Ren, F. et al. (2010) Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma. Mol. Cancer, 9, 81.
15. Halbert, C.L. et al. (1992) The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol., 66, 2125-2134.
16. Illingworth, N.A. et al. (2010) Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDPglucuronosyltransferases. Br. J. Pharmacol., 162, 989-999.
17. Villani, M.G. et al. (2004) Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1. Clin. Cancer Res., 10, 6265-6275.
18. Abou-Issa, H. et al. (1997) Chemotherapeutic evaluation of N-(4-hydroxyphenyl)retainamide-O-glucuronide in the rat mammary tumor model. Anticancer Res., 17, 3335-3339.
19. Rinaldi, A.L. et al. (2002) Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma and oral mucosa. Cancer Res., 62, 5451-5456.
20. Wu, X. et al. (2012) Mucoadhesive fenretinide patches for site-specific chemoprevention of oral cancer: enhancement of oral mucosal permeation of fenretinide by co-incorporation of propylene glycol and menthol. Mol. Pharm., in press., doi: 10.1021/mp200655k
21. Lippens, S. et al. (2005) Death penalty for keratinocytes: apoptosis versus cornification. Cell Death Differ., 12, 1497-1508.
22. Candi, E. et al. (2005) The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol., 6, 328-340.
23. Lesort, M. et al. (1998) Distinct nuclear localization and activity of tissue transglutaminase. J. Biol. Chem., 273, 11991-11994.
24. Tatsukawa, H. et al. (2011) Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells. Mol. Cancer, 10, 4.
25. Smith, J. et al. (2009) Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol., 45, 647-653.